stella
beta
Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR) — Stella
Recruiting
Back to Peripheral T Cell Lymphoma trials
Trial locations
(1 site)
China
Shanghai General Hospital, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov